New York State Teachers Retirement System (NYSTRS)’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,401
Closed -$424K 1640
2023
Q1
$424K Buy
2,401
+3
+0.1% +$1K ﹤0.01% 1441
2022
Q4
$927K Hold
2,398
﹤0.01% 1287
2022
Q3
$808K Buy
2,398
+219
+10% +$79.3K ﹤0.01% 1301
2022
Q2
$716K Buy
2,179
+867
+66% +$304K ﹤0.01% 1334
2022
Q1
$574K Buy
1,312
+514
+64% +$211K ﹤0.01% 1400
2021
Q4
$350K Buy
798
+436
+120% +$219K ﹤0.01% 1484
2021
Q3
$202K Sell
362
-109
-23% -$54.7K ﹤0.01% 1542
2021
Q2
$242K Buy
+471
New +$298K ﹤0.01% 1505

Other funds holding TVRD

New York State Teachers Retirement System (NYSTRS)'s TVRD Position: Q2 2023 in Review

New York State Teachers Retirement System (NYSTRS) sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 2,401 shares — an estimated $424K sold.

New York State Teachers Retirement System (NYSTRS) first reported a position in TVRD in Q2 2021 and held it in 8 quarters. The position peaked at $927K in Q4 2022. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

  • New York State Teachers Retirement System (NYSTRS) reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
  • New York State Teachers Retirement System (NYSTRS) sold 2,401 Tvardi Therapeutics shares in Q2 2023, an estimated $424K.
  • New York State Teachers Retirement System (NYSTRS) first reported a position in Tvardi Therapeutics in Q2 2021 and held it in 8 quarters.
  • New York State Teachers Retirement System (NYSTRS)'s Tvardi Therapeutics position peaked at $927K in Q4 2022.
  • 137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q2 2023, filed 27 Jul 2023.